AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
+6.69%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$2.48B
AUM Growth
+$2.48B
(+19%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
8.39%
Top 10 Holdings %
Top 10 Hldgs %
85.69%
Holding
35
New
4
Increased
–
Reduced
6
Closed
3
Top Buys
| 1 |
Oscar Health
OSCR
|
$646M |
| 2 |
Sana Biotechnology
SANA
|
$94.1M |
| 3 |
Clover Health Investments
CLOV
|
$31.1M |
| 4 |
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
|
$18.6M |
Top Sells
| 1 |
Lyft
LYFT
|
$325M |
| 2 |
Twilio
TWLO
|
$161M |
| 3 |
Lemonade
LMND
|
$60.3M |
| 4 |
Aterian
ATER
|
$10.1M |
| 5 |
Arcus Biosciences
RCUS
|
$9.17M |
Sector Composition
| 1 | Healthcare | 61.01% |
| 2 | Technology | 18.87% |
| 3 | Industrials | 8.59% |
| 4 | Consumer Discretionary | 5.24% |
| 5 | Financials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Oscar Health
OSCR
$4.31B
| $646M | 26.05% | +24,042,864 | New | +$646M |
|
|
2
Lyft
LYFT
$6.73B
| $406M | 16.35% | 6,420,985 -5,149,539 | -45% | -$325M |
|
3
DexCom
DXCM
$29.5B
| $290M | 11.67% | 805,681 | – | – |
|
|
DM
4
DELISTED
Desktop Metal, Inc.
DM
| $213M | 8.59% | 14,302,438 | – | – |
|
|
5
Arcus Biosciences
RCUS
$1.13B
| $133M | 5.35% | 4,723,348 -326,438 | -6% | -$9.17M |
|
6
Airbnb
ABNB
$79.9B
| $130M | 5.24% | 691,612 | – | – |
|
7
Upstart Holdings
UPST
$7.05B
| $107M | 4.32% | 832,423 | – | – |
|
|
8
Sana Biotechnology
SANA
$777M
| $94.1M | 3.8% | +2,812,500 | New | +$94.1M |
|
9
Relay Therapeutics
RLAY
$619M
| $54.2M | 2.19% | 1,568,486 -233,004 | -13% | -$8.05M |
|
|
WORK
10
DELISTED
Slack Technologies, Inc.
WORK
| $52.8M | 2.13% | 1,299,771 | – | – |
|
11
Beam Therapeutics
BEAM
$1.66B
| $51.3M | 2.07% | 640,792 -22,899 | -3% | -$1.83M |
|
|
KRON
12
DELISTED
Kronos Bio
KRON
| $42.1M | 1.7% | 1,438,232 | – | – |
|
13
Dianthus Therapeutics
DNTH
$759M
| $39.5M | 1.59% | 3,339,138 | – | – |
|
|
14
Clover Health Investments
CLOV
$1.34B
| $31.1M | 1.25% | +4,113,742 | New | +$31.1M |
|
15
Opendoor
OPEN
$3.27B
| $26.5M | 1.07% | 1,250,997 | – | – |
|
|
DBTX
16
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $18.6M | 0.75% | +1,636,258 | New | +$18.6M |
|
17
RAPT Therapeutics
RAPT
$188M
| $18.5M | 0.74% | 831,254 | – | – |
|
18
IDEAYA Biosciences
IDYA
$2.15B
| $17.7M | 0.71% | 753,187 | – | – |
|
|
19
Lemonade
LMND
$3.91B
| $16.5M | 0.67% | 177,698 -647,045 | -78% | -$60.3M |
|
20
Spero Therapeutics
SPRO
$116M
| $13.1M | 0.53% | 889,979 | – | – |
|
21
Taysha Gene Therapies
TSHA
$797M
| $13M | 0.52% | 640,882 | – | – |
|
|
SQZ
22
DELISTED
SQZ Biotechnologies Company
SQZ
| $11.4M | 0.46% | 831,389 | – | – |
|
|
EVLO
23
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $11.3M | 0.46% | 1,060,495 | – | – |
|
24
Fulcrum Therapeutics
FULC
$351M
| $7.99M | 0.32% | 678,141 | – | – |
|
25
Quince Therapeutics
QNCX
$85.9M
| $6.81M | 0.27% | 189,122 | – | – |
|